E.E. Geduld’s Bristol-Myers Squibb BMY Stock Holding History

E.E. Geduld’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.78M	Hold	47,500	–	–	1.56%	4
2016 Q3	$2.56M	Buy	47,500 +27,500	+138%	+$1.77M	2.55%	2
2016 Q2	$1.47M	Buy	20,000 +7,500	+60%	+$530K	1.93%	3
2016 Q1	$799K	Sell	12,500 -12,500	-50%	-$788K	1.1%	11
2015 Q4	$1.72M	Hold	25,000	–	–	1.06%	6
2015 Q3	$1.48M	Buy	+25,000	New	+$1.59M	1.39%	8

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

E.E. Geduld's BMY Position: Q4 2016 in Review

E.E. Geduld held its Bristol-Myers Squibb (BMY) position steady in Q4 2016 at 47,500 shares worth $2.78M. The position accounts for 1.56% of the portfolio, ranked #4.

E.E. Geduld first reported a position in BMY in Q3 2015 and has held it in 6 quarters since. 1,602 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

E.E. Geduld held 47,500 shares of Bristol-Myers Squibb worth $2.78M as of Q4 2016.
E.E. Geduld left its Bristol-Myers Squibb share count unchanged in Q4 2016.
Bristol-Myers Squibb made up 1.56% of E.E. Geduld's portfolio in Q4 2016, its #4 holding.
E.E. Geduld first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 6 quarters since.
1,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.